Author:
Miller Rachel,Schlueter Annette
Publisher
Springer International Publishing
Reference142 articles.
1. Valent P. Low blood counts: immune mediated, idiopathic, or myelodysplasia. Hematology Am Soc Hematol Educ Program. 2012;2012:485–91.
2. Dale DC, Cottle TE, Fier CJ, Bolyard AA, Bonilla MA, Boxer LA, et al. Severe chronic neutropenia: treatment and follow-up of patients in the severe chronic neutropenia international registry. Am J Hematol. 2003;72(2):82–93.
3. Common Terminology Criteria for Adverse Events (CTCAE): National Cancer Institute. 2018. Available from: https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/aeguidelines.pdf.
4. Zafrani L, Truffaut L, Kreis H, Etienne D, Rafat C, Lechaton S, et al. Incidence, risk factors and clinical consequences of neutropenia following kidney transplantation: a retrospective study. Am J Transplant. 2009;9(8):1816–25.
5. Poon T, Guerra CM. Evaluation of Filgrastim therapy in kidney transplant recipients. Prog Transplant. 2017;27(4):360–4.